Uncertainty still surrounds oseltamivir after 13 year old diesBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7532.5 (Published 05 January 2006) Cite this as: BMJ 2006;332:5
- Jane Parry
- Hong Kong
Not enough studies have yet been done to determine the most effective way of using the antiviral drug oseltamivir (Tamiflu) and other antivirals against the H5N1 strain of avian influenza, a leading expert has warned. “In terms of dose, time, or strategy, all the studies have so far been done on H3N1 and H1N1 flu,” said Professor Robert Webster, of the division of virology at St Jude Children's Research Hospital, Memphis, Tennessee, and visiting professor at the University of Hong Kong's department of virology. “It is inevitable that we will get …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial